b-rayZ is a spinoff of the University Hospital of Zurich. We develop AI software that supports the daily work of the radiologist in mammography with a real-time assessment of image quality and breast density. We believe that AI can supplement the visual inspection of radiologists in quality assurance and breast density assessment. With us, you can focus on your clinical work and rely on better image quality.
Early detection of breast cancer by mammography is difficult in patients with dense breast tissue and in poor-quality images. Nowadays after each exam, radiologists rate mammographies in terms of breast density and diagnostic quality, which is costly, slow, and doctor-dependent practice. The b-box uses AI algorithms to emulate doctor decisions and provides real-time feedback on breast density and image quality.
B2B
1 to 25
Series A
$4.28M
Scaling Up
2019
Medical Devices
Healthcare
96% Clinical Accuracy
+1.5M High Quality Data Sets
Increase Efficiency
Analytics
Yes
Active
Machine Learning
Software
Mar 2022
- b-rayZ Partnered with Irdeto
4
1
$4M
Company was founded 2019 and it took almost 3 years (Jul 2022) to raise first external round
Investors
Interested in researching b-rayZ?
We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about b-rayZ
Potential Customers
